Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Summer;14(3):19-32.

Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms

Affiliations
Review

Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms

Parvaneh Karimzadeh et al. Iran J Child Neurol. 2020 Summer.

Abstract

Neurometabolic disorders are hereditary conditions mainly affect the function of the brain and the nervous system. The prevalence of these disorders is 1 in 1,000 live births. Such disorders, at different ages, could manifest as sepsis, hypoglycemia, and other neurologic disorders. Having similar manifestations leads to delayed diagnosis of neurometabolic disorders. A number of neurometabolic disorders have known treatments; however, to prevent long-term complications the key factors are early diagnosis and treatment. Although a large number of neurometabolic diseases have no treatment or cure, the correct and on-time diagnosis before death is important for parents to have plans for prenatal diagnosis. Different diagnostic procedures could be offered to parents, enzymatic procedures, and determining metabolites in plasma, urine, and CSF, and molecular genetic diagnosis. Molecular genetic diagnostic procedures are expensive and could not be offered to all parents. Therefore, we aimed to design algorithms to diagnose neurometabolic disorders according to some frequent and characteristic signs and symptoms. By designing these algorithms and using them properly, we could offer diagnostic enzymatic panels. These enzymatic panels are inexpensive; thereby reducing the financial burden on the parents. Also, having an early diagnosis according to these panels could lead to offering more accurate and less expensive molecular genetic tests.

Keywords: Neurometabolic disorders; algorithms; children; diagnosis; enzymatic panels.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cherry-red spot at fundoscopy
Algorithm 1
Algorithm 1
Diagnostic approach to neurometabolic disorders with a cherry-red spot
Algorithm 2
Algorithm 2
Approach to neurometabolic disorders with chronic subdural effusion and hematomas
Algorithm 3.
Algorithm 3.
Approach to neurometabolic disorders with alopecia and global developmental delay
Figure 2
Figure 2
Extensive Mongolian spot
Algorithm 4.
Algorithm 4.
Diagnostic approach to neonates and infants with extensive Mongolian spots
Algorithm 5
Algorithm 5
Diagnostic approach in patients with hyperammonemia
Algorithm 6
Algorithm 6
Diagnostic approach to a patient with hypertyrosinemia

Similar articles

Cited by

References

    1. Filiano JJ. Neurometabolic diseases in the newborn. Clin Perinatol. 2006;33(2):411–79. - PubMed
    1. Fernandes Filho JA, Shapiro BE. Tay-Sachs disease. Arch Neurol. 2004;61(9):1466–8. - PubMed
    1. Suvarna JC, Hajela SA. Cherry-red spot. J Postgrad Med. 2008;54(1):54–7. - PubMed
    1. Gieselmann V, Franken S, Klein D, Mansson JE, Sandhoff R, Lullmann Rauch R, et al. Metachromatic leukodystrophy: consequences of sulphatide accumulation. Acta Paediatr Suppl. 2003;92(443):74–9; discussion 45. - PubMed
    1. Dierks T, Schlotawa L, Frese MA, Radhakrishnan K, von Figura K, Schmidt B. Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins. Biochim Biophys Acta. 2009;1793(4):710–25. - PubMed

LinkOut - more resources